Indeed, over-expression of both cyclinB1 and CDC25, important regulators of CDK1 activity, are prognostic markers in colorectal and other cancers (Takemasa et al, 2000; Korenaga et al, 2002; Suzuki et al, 2007). Here, CDK1 is linked to cancer.